logo
logo

PulseMedica Corp. raises $12 million CAD in a Pre-Series A financing round, led by Saltagen Ventures, to advance eye floater imaging and treatment technology.

Jul 16, 202412 months ago

Amount Raised

$12 Million

Round Type

series a

EdmontonHealth DiagnosticsMedical DeviceMedicalBiotechnologyHealth Care

Investors

University Of Alberta’s Innovation FundStartup TntU Ceed Health FundThreshold ImpactScale Good FundAccelerate Fund IiiSaltagen Ventures

Description

PulseMedica Corp. has raised an aggregate of $12 million CAD to date in investment as part of their pre-Series A financing round. The investment allowed PulseMedica to generate exciting initial results from their preclinical and clinical studies and will continue to accelerate the clinical validation of PulseMedica’s innovative floater imaging device. Additionally, the investment supports ongoing laser safety and feasibility studies essential for the first-in-human clinical trial for floater treatment

Company Information

Company

PulseMedica

Location

Edmonton, England, United Kingdom

About

PulseMedica has developed a proprietary real-time 3D imaging and laser targeting system for precise retinal surgery. Our patented next generation ultrafast femtosecond laser ophthalmic treatment will enable treatment for retinal diseases such as age-related macular degeneration (AMD) and glaucoma, for which there is currently no cure. PulseMedica is a company based out of Edmonton, AB, Canada.

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People